Home Cart Sign in  
Chemical Structure| 2905-56-8 Chemical Structure| 2905-56-8

Structure of 2905-56-8

Chemical Structure| 2905-56-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Molly M. Sherard ; Jamie S. Kaplan ; Jeffrey H. Simpson ; Kevin W. Kittredge ; Michael C. Leopold ;

Abstract: Fentanyl (FTN) and synthetic analogs of FTN continue to ravage populations across the globe, including in the United States where opioids are increasingly being used and abused and are causing a staggering and growing number of overdose deaths each year. This growing pandemic is worsened by the ease with which FTN can be derivatized into numerous derivatives. Understanding the chemical properties/behaviors of the FTN class of compounds is critical for developing effective chemical detection schemes using nanoparticles (NPs) to optimize important chemical interactions. Halogen bonding (XB) is an intermolecular interaction between a polarized halogen atom on a molecule and e−-rich sites on another molecule, the latter of which is present at two or more sites on most fentanyl-type structures. Density functional theory (DFT) is used to identify these XB acceptor sites on different FTN derivatives. The high toxicity of these compounds necessitated a “fragmentation” strategy where smaller, non-toxic molecules resembling parts of the opioids acted as mimics of XB acceptor sites present on intact FTN and its derivatives. DFT of the fragments’ interactions informed solution measurements of XB using 19F NMR titrations as well as electrochemical measurements of XB at self-assembled monolayer (SAM)-modified electrodes featuring XB donor ligands. Gold NPs, known as monolayer-protected clusters (MPCs), were also functionalized with strong XB donor ligands and assembled into films, and their interactions with FTN “fragments” were studied using voltammetry. Ultimately, spectroscopy and TEM analysis were combined to study whole-molecule FTN interactions with the functionalized MPCs in solution. The results suggested that the strongest XB interaction site on FTN, while common to most of the drug’s derivatives, is not strong enough to induce NP-aggregation detection but may be better exploited in sensing schemes involving films.

Keywords: opioid ; fentanyl ; halogen bonding ; gold nanoparticle ; monolayer-protected cluster ; cyclic voltammetry

Purchased from AmBeed: ;

Alternative Products

Product Details of [ 2905-56-8 ]

CAS No. :2905-56-8
Formula : C12H17N
M.W : 175.27
SMILES Code : C(N1CCCCC1)C1=CC=CC=C1
MDL No. :MFCD00224901
InChI Key :NZVZVGPYTICZBZ-UHFFFAOYSA-N
Pubchem ID :76190

Safety of [ 2905-56-8 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P305+P351+P338

Computational Chemistry of [ 2905-56-8 ] Show Less

Physicochemical Properties

Num. heavy atoms 13
Num. arom. heavy atoms 6
Fraction Csp3 0.5
Num. rotatable bonds 2
Num. H-bond acceptors 1.0
Num. H-bond donors 0.0
Molar Refractivity 60.14
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

3.24 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

2.59
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

2.6
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

2.14
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

2.67
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

2.94
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

2.59

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-2.77
Solubility 0.295 mg/ml ; 0.00168 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-2.32
Solubility 0.844 mg/ml ; 0.00482 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-3.52
Solubility 0.0526 mg/ml ; 0.0003 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

Low
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

Yes
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-5.52 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

2.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.0

Application In Synthesis of [ 2905-56-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 2905-56-8 ]

[ 2905-56-8 ] Synthesis Path-Downstream   1~35

  • 1
  • [ 110-89-4 ]
  • [ 93-89-0 ]
  • [ 2905-56-8 ]
  • 3
  • [ 110-89-4 ]
  • [ 107-31-3 ]
  • [ 100-52-7 ]
  • [ 2905-56-8 ]
  • 4
  • [ 110-89-4 ]
  • [ 100-52-7 ]
  • [ 2905-56-8 ]
References: [1]Bulletin of the Korean Chemical Society,2010,vol. 31,p. 1927 - 1930.
[2]Synthetic Communications,2010,vol. 40,p. 951 - 956.
[3]Journal of the Iranian Chemical Society,2010,vol. 7,p. 428 - 431.
[4]Turkish Journal of Chemistry,2010,vol. 34,p. 307 - 312.
[5]Chinese Chemical Letters,2010,vol. 21,p. 47 - 50.
[6]Synthesis,2011,p. 490 - 496.
[7]Synthetic Communications,2009,vol. 39,p. 2907 - 2916.
[8]Tetrahedron Letters,2009,vol. 50,p. 659 - 661.
[9]Tetrahedron Letters,2007,vol. 48,p. 1273 - 1276.
[10]Chemical Communications,2018,vol. 54,p. 4302 - 4305.
[11]Monatshefte fur Chemie,2008,vol. 139,p. 21 - 25.
[12]Synthetic Communications,1993,vol. 23,p. 1595 - 1599.
[13]Synlett,2000,p. 1655 - 1657.
[14]Tetrahedron Letters,2010,vol. 51,p. 3167 - 3169.
[15]Synlett,2006,p. 431 - 434.
[16]Synthetic Communications,2008,vol. 38,p. 1976 - 1983.
[17]Green Chemistry,2021,vol. 23,p. 5205 - 5211.
[18]Chemical Communications,2009,p. 6207 - 6209.
[19]Tetrahedron Letters,2007,vol. 48,p. 8807 - 8810.
[20]Canadian Journal of Chemistry,2012,vol. 90,p. 701 - 707,7.
[21]Journal of Organic Chemistry,1990,vol. 55,p. 2552 - 2554.
[22]Journal of Organic Chemistry,2021,vol. 86,p. 4274 - 4280.
[23]Angewandte Chemie - International Edition,2017,vol. 56,p. 9512 - 9516.
    Angew. Chem.,2017,vol. 129,p. 9640 - 9644,5.
[24]Journal of Organic Chemistry,2014,vol. 79,p. 6196 - 6205.
[25]RSC Advances,2015,vol. 5,p. 2292 - 2298.
[26]Tetrahedron,2008,vol. 64,p. 1213 - 1217.
[27]Justus Liebigs Annalen der Chemie,1905,vol. 343,p. 52.
    Justus Liebigs Annalen der Chemie,1907,vol. 353,p. 292.
    Chemisches Zentralblatt,1907,vol. 78,p. 53.
[28]Journal of Organic Chemistry,1949,vol. 14,p. 559,572.
[29]Tetrahedron Letters,2009,vol. 50,p. 6658 - 6660.
[30]Catalysis Letters,2012,vol. 142,p. 389 - 396.
[31]RSC Advances,2014,vol. 4,p. 20454 - 20458.
[32]Catalysis Letters,2014,vol. 144,p. 1568 - 1572,5.
[33]RSC Advances,2015,vol. 5,p. 81395 - 81398.
[34]Patent: US2108147,1934,A .
    Fortschr. Teerfarbenfabr. Verw. Industriezweige,vol. 22,p. 183.
    Fortschr. Teerfarbenfabr. Verw. Industriezweige,vol. 22,p. 183.
[35]Advanced Synthesis and Catalysis,2018,vol. 360,p. 4699 - 4704.
[36]Organic Process Research and Development,2020,vol. 24,p. 1647 - 1657.
  • 5
  • [ 110-89-4 ]
  • [ 100-44-7 ]
  • [ 2905-56-8 ]
YieldReaction ConditionsOperation in experiment
97% With tetrabutylammomium bromide; sodium hydroxide; In water; at 100℃; for 1h; General procedure: SiO2-CuI (0.1 g,5 mol% Cu) was added to a mixture of amine (0.5 mmol), benzyl chloride, allyl bromide, or n-butyl chloride (0.5 mmol for N-substitution and 1 mmol for N,N-disubstitution), NaOH (2 mmol), and TBAB (0.25 mmol) in a round-bottom flask(25 mL) in water (4mL). The reaction mixture was stirred at 15C (in the case of N-benzylation, allylation, or alkylation of primary amines,Table 2) or 70-100C (in the case of N,N-dibenzylation, allylation, or alkylation of primary amines, Table 3), and 100C(N-benzylation, allylation, and alkylation of secondary amines, Table 4) for an appropriate time. After completion of the reaction (monitored by thin-layer chromatography, TLC), the reaction mixture was triturated with EtOAc (20 mL) and the SiO2-CuI was filtered off. The product was obtained after removal of the solvent under reduced pressure followed by column chromatography or crystallization from EtOAc-petroleum ether.
90% With silica copper(I) oxide; tetrabutylammomium bromide; potassium carbonate; In water; at 100℃; for 0.5h;Green chemistry; General procedure: A mixture of secondary amine (0.5 mmol), benzyl chloride (0.127 g, 1 mmol), K2CO3 (0.139 g, 1 mmol), TBAB (0.082 g,0.25 mmol), and SiO2-Cu2O (0.2 g, 5 mol% Cu) in water (5 mL) in a round-bottom flask (50 mL) was stirred at 100 C. On completionof the reaction (monitored by TLC), the flask was cooledto room temperature and the mixture filtered. The residue was washed with water followed by ethyl acetate (3 × 10 mL). The combined organic extracts were washed with water (3 × 100mL) and dried over anhydrous Na2SO4. The solvent was removed under reduced pressure, and the product was obtainedby crystallization from petroleum ether or ethyl acetate/ petroleumether, or by eluting the crude product through a columnof silica gel with ethyl acetate/petroleum ether.
76% With trimethylamine; In dichloromethane; at 20℃; for 6h;Inert atmosphere; General procedure: Typical procedure: A solution of piperidine (0.84 g, 10.0 mmol), trimethylamine (1.01 g, 10.0 mmol) in dry CH2Cl2 (2 mL) under nitrogen atmosphere was cooled with an ice-water bath, then a solution of generation 1 bromide (3.83 g, 10.0 mmol) in dry CH2Cl2 (5mL) was slowly added. The mixture was stirred for 6 h at room temperature (TLC monitoring). After completion of the reaction, the crude product was puried by ash column chromatography on silica gel (petroleum ether: ethyl acetate 6:1,v/v) to afford 1-G1 as lightly yellow oil liquid.
  • 6
  • [ 18811-61-5 ]
  • [ 60-29-7 ]
  • [ 591-51-5 ]
  • [ 2905-56-8 ]
  • 7
  • [ 776-75-0 ]
  • [ 2905-56-8 ]
YieldReaction ConditionsOperation in experiment
84% General procedure: In a nitrogen-filled glovebox, to a 15 mL reaction tube equipped with a magnetic stirrer, were added Cp2ZrH2 (0.01mmol, 2.2 mg) as the catalyst, and the appropriate amide (0.2mmol); solvent was added when necessary. HBpin (3 equiv. peramide functional group) was then added, and the reaction tube was taken out from the glovebox and stirred at room temperature for 12-48 h. The resultant crude amines were either isolated using silica gel flash chromatography, or acidified by stirring with HCl in Et2O (2 mL, 1N) for 2 h, after which time precipitation was observed. Then, the reaction solution was transferred to a centrifuge tube and centrifuged three times. The supernatant was removed and the resulting solid was dried inan oven at 80 C for several hours to obtain the HCl salt of the amine.
References: [1]Angewandte Chemie - International Edition,2009,vol. 48,p. 9507 - 9510.
[2]Organic Letters,2015,vol. 17,p. 446 - 449.
[3]Journal of Organic Chemistry,2014,vol. 79,p. 7728 - 7733.
[4]Chemical Communications,2018,vol. 54,p. 5855 - 5858.
[5]Advanced Synthesis and Catalysis,2013,vol. 355,p. 3358 - 3362.
[6]Bulletin of the Polish Academy of Sciences: Chemistry,1986,vol. 34,p. 205 - 218.
[7]Chemical Communications,2013,vol. 49,p. 9758 - 9760.
[8]Advanced Synthesis and Catalysis,2016,vol. 358,p. 452 - 458.
[9]Organometallics,2013,vol. 32,p. 7440 - 7444.
[10]Chemical Communications,2021,vol. 57,p. 9204 - 9207.
[11]European Journal of Organic Chemistry,2013,p. 2066 - 2070.
[12]Journal of the American Chemical Society,2008,vol. 130,p. 18 - 19.
[13]Journal of Organic Chemistry,2021,vol. 86,p. 15992 - 16000.
[14]Tetrahedron,1998,vol. 54,p. 10899 - 10914.
[15]Journal of the American Chemical Society,2010,vol. 132,p. 1770 - 1771.
[16]Chemistry - A European Journal,2011,vol. 17,p. 1768 - 1772.
[17]Advanced Synthesis and Catalysis,2019,vol. 361,p. 4817 - 4824.
[18]Cuihua Xuebao/Chinese Journal of Catalysis,2021,vol. 42,p. 2059 - 2067.
[19]ChemCatChem,2017,vol. 9,p. 2009 - 2017.
[20]Chemistry - A European Journal,2011,vol. 17,p. 12186 - 12192.
[21]Advanced Synthesis and Catalysis,2013,vol. 355,p. 2775 - 2780.
[22]ChemCatChem,2019,vol. 11,p. 3818 - 3827.
[23]Tetrahedron Letters,2008,vol. 49,p. 6873 - 6875.
[24]European Journal of Organic Chemistry,2014,vol. 2014,p. 5144 - 5148.
[25]Chemische Berichte,1899,vol. 32,p. 74.
[26]Archiv der Pharmazie,1927,p. 390,400.
    Chemisches Zentralblatt,1924,vol. 95,p. 1404.
[27]Journal of Organic Chemistry,1953,vol. 18,p. 1190,1196.
[28]Journal of Organic Chemistry,1981,vol. 46,p. 3730 - 3732.
[29]Journal of the American Chemical Society,2008,vol. 130,p. 933 - 944.
[30]Journal of the American Chemical Society,2012,vol. 134,p. 640 - 653.
[31]New Journal of Chemistry,2014,vol. 38,p. 1694 - 1700.
[32]Chemical Communications,2014,vol. 50,p. 9349 - 9352.
[33]Chemical Communications,2016,vol. 52,p. 1855 - 1858.
[34]Angewandte Chemie - International Edition,2017,vol. 56,p. 15901 - 15904.
    Angew. Chem.,2017,vol. 129,p. 16117 - 16120,4.
[35]Patent: DE164365,1904,C .
    Fortschr. Teerfarbenfabr. Verw. Industriezweige,vol. 8,p. 1053.
    Fortschr. Teerfarbenfabr. Verw. Industriezweige,vol. 8,p. 1053.
[36]Patent: DE164365,1904,C .
    Fortschr. Teerfarbenfabr. Verw. Industriezweige,vol. 8,p. 1053.
    Fortschr. Teerfarbenfabr. Verw. Industriezweige,vol. 8,p. 1053.
[37]Journal of the American Chemical Society,2020,vol. 142,p. 8019 - 8028.
[38]Dalton Transactions,2021,vol. 50,p. 2354 - 2358.
[39]Angewandte Chemie - International Edition,2021,vol. 60,p. 16035 - 16043.
    Angew. Chem.,2021,vol. 133,p. 16171 - 16179.
  • 8
  • [ 94067-00-2 ]
  • phenylmagnesium bromide [ No CAS ]
  • [ 2905-56-8 ]
  • 10
  • [ 628-21-7 ]
  • [ 2905-56-8 ]
  • [ 121968-63-6 ]
  • 11
  • [ 628-77-3 ]
  • [ 2905-56-8 ]
  • [ 121812-61-1 ]
  • 12
  • [ 64-17-5 ]
  • [ 6633-92-7 ]
  • [ 2905-56-8 ]
  • [ 91061-28-8 ]
  • 13
  • [ 6633-92-7 ]
  • [ 2905-56-8 ]
  • [ 91061-28-8 ]
  • 14
  • [ 1600-27-7 ]
  • [ 64-19-7 ]
  • [ 2905-56-8 ]
  • [ 102666-89-7 ]
  • 15
  • [ 96-32-2 ]
  • [ 2905-56-8 ]
  • [ 61533-06-0 ]
  • 16
  • [ 2905-56-8 ]
  • [ 106-95-6 ]
  • [ 22100-11-4 ]
  • 17
  • [ 2905-56-8 ]
  • [ 70-11-1 ]
  • 1-benzyl-1-phenacyl-piperidinium; bromide [ No CAS ]
  • 19
  • [ 2905-56-8 ]
  • [ 868-26-8 ]
  • [ 1733-15-9 ]
  • 20
  • [ 2905-56-8 ]
  • [ 29872-25-1 ]
YieldReaction ConditionsOperation in experiment
98% With dihydrogen peroxide; benzonitrile;Mg-Al-O-t-Bu HT (Catalyst B); In methanol; water; at 65℃; for 0.75h;Product distribution / selectivity; Oxidation of various tertiary amines using catalyst B was carried out following the procedure as in example 2 and the results are given in Table 2.
  • 21
  • [ 2905-56-8 ]
  • [ 59507-46-9 ]
  • 22
  • [ 2905-56-8 ]
  • [ 102666-89-7 ]
  • 23
  • [ 2905-56-8 ]
  • 1-benzyl-piperidine-1-oxide ; 1-benzyl-piperidine-1-oxide-hydrogen peroxid-adduct [ No CAS ]
  • 24
  • [ 111-29-5 ]
  • [ 100-46-9 ]
  • [ 2905-56-8 ]
YieldReaction ConditionsOperation in experiment
83% With bis[dichloro(pentamethylcyclopentadienyl)iridium(III)]; Bis(p-nitrophenyl) phosphate; In toluene; at 100℃; for 36h;Sealed tube; Molecular sieve; Green chemistry; General procedure: Amine 11 (399.3 mg, 2.0 mmol, 1.0 eq.), diol 14 (379.7 mg, 2.4 mmol, 1.0eq.), were added to a sealed tube, 5.0 mL of toluene was added and stirred. Then [Ir] catalyst 15 (79.7 mg, 0.1 mmol, 0.05eq.) and phosphoric acid 16 (68.1 mg, 0.2 mmol, 0.1eq.), 4 molecular sieve (500.1 mg) was added, heated at 100 C for 36h. The reaction mass was allowed to cool to rt, then washed with 5% NaHCO3 solution, water, evaporated under vacuum. The crude mass was purified by silica gel column chromatography, eluted with 5% ethyl acetate in n-hexane to give clopidogrel (4) as a yellow oil.
  • 27
  • [ 110-89-4 ]
  • [ 47484-87-7 ]
  • [ 2905-56-8 ]
  • 29
  • [ 110-89-4 ]
  • [ 76017-39-5 ]
  • [ 67913-78-4 ]
  • [ 2905-56-8 ]
  • 30
  • [ 110-89-4 ]
  • [ 75505-88-3 ]
  • [ 2905-56-8 ]
  • 31
  • [ 110-89-4 ]
  • [ 75505-89-4 ]
  • [ 2905-56-8 ]
  • 32
  • [ 110-89-4 ]
  • [ 75505-95-2 ]
  • [ 2905-56-8 ]
  • 33
  • [ 110-89-4 ]
  • [ 75505-90-7 ]
  • [ 2905-56-8 ]
  • 34
  • [ 110-89-4 ]
  • [ 75505-92-9 ]
  • [ 2905-56-8 ]
  • 35
  • [ 110-89-4 ]
  • [ 75505-91-8 ]
  • [ 2905-56-8 ]
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 2905-56-8 ]

Aryls

Chemical Structure| 29897-82-3

A383339 [29897-82-3]

1-Benzylpyrrolidine

Similarity: 0.91

Chemical Structure| 102-05-6

A487638 [102-05-6]

N-Benzyl-N-methyl-1-phenylmethanamine

Similarity: 0.90

Chemical Structure| 1205-72-7

A199210 [1205-72-7]

1-Benzylpiperidin-4-amine dihydrochloride

Similarity: 0.89

Chemical Structure| 40240-12-8

A278850 [40240-12-8]

1-Benzyl-1,2,3,6-tetrahydropyridine

Similarity: 0.88

Chemical Structure| 6913-92-4

A495353 [6913-92-4]

1-Benzyl-3-pyrroline

Similarity: 0.88

Related Parent Nucleus of
[ 2905-56-8 ]

Piperidines

Chemical Structure| 1205-72-7

A199210 [1205-72-7]

1-Benzylpiperidin-4-amine dihydrochloride

Similarity: 0.89

Chemical Structure| 60407-35-4

A129898 [60407-35-4]

1-Benzylpiperidin-3-amine

Similarity: 0.86

Chemical Structure| 29608-05-7

A150486 [29608-05-7]

4-(Piperidin-1-ylmethyl)aniline

Similarity: 0.86

Chemical Structure| 368429-78-1

A200174 [368429-78-1]

1-Benzylpiperidin-3-amine hydrochloride

Similarity: 0.84

Chemical Structure| 4727-72-4

A612978 [4727-72-4]

1-Benzylpiperidin-4-ol

Similarity: 0.84